Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01477723 · ClinicalTrials.gov registry record · Phase 3

Evaluation of an Oral Nutritional Supplement in Older Hospitalized Patients

A Phase 3 study, sponsored by Abbott Nutrition.

Terminated
Registry status
Phase 3
Development phase
17
Enrollment target

NCT01477723 is a Phase 3 study that was terminated before completion, run by Abbott Nutrition. The registered enrollment target is 17 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01477723, a Phase 3 study, was terminated before completion, sponsored by Abbott Nutrition.

TERMINATED
Registry status
Phase 3
Development phase
17 participants
Enrollment target

Study Summary

Study objectives are to verify the loss of lean mass during a hospital stay in a group of older patients; to evaluate the effects of consuming a high-calorie complete and balanced oral nutritional supplement; to collect post-discharge information.

Interventions

  • OTHER Experimental Oral Nutritional Supplement

Trial Details

FieldValue
Enrollment Target 17 participants
Start Date 2011-10
Est. Completion 2012-11
Phase Phase 3

Sponsor

Abbott Nutrition

89 total trials

What the Registry Record Tells You About NCT01477723

The ClinicalTrials.gov registry entry for NCT01477723 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Nutrition, which has 89 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Experimental Oral Nutritional Supplement is the first listed.

NCT01477723 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01477723 about?

NCT01477723 is a clinical study titled "Evaluation of an Oral Nutritional Supplement in Older Hospitalized Patients". Study objectives are to verify the loss of lean mass during a hospital stay in a group of older patients; to evaluate the effects of consuming a high-calorie complete and balanced oral nutritional supplement; to collect post-discharge information.

What is the current status of trial NCT01477723?

This trial is currently terminated. It is a Phase 3 study. The enrollment target is 17 participants. The study started on 2011-10. Estimated completion is 2012-11.

What interventions are being tested in trial NCT01477723?

The interventions under investigation include: Experimental Oral Nutritional Supplement (OTHER).

Who is sponsoring clinical trial NCT01477723?

This trial is sponsored by Abbott Nutrition, which has 89 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.